Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
NCT05235165 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2026-05-05
Summary
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Conditions
- Metastatic Malignant Neoplasm in the Lung
- Metastatic Osteosarcoma
- Osteosarcoma
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo collection of tissue and blood
- PROCEDURE
-
Computed Tomography
Undergo CT
- OTHER
-
Questionnaire Administration
Ancillary studies
- PROCEDURE
-
Thoracoscopy
Undergo video-assisted thoracoscopic surgery or VATS
- PROCEDURE
-
Thoracotomy
Undergo open thoracic surgery
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Children's Oncology Group
lead NETWORK
Principal Investigators
-
John J Doski · Children's Oncology Group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-01
- Primary Completion
- 2031-03-31
- Completion
- 2031-03-31
- FDA Device
- Yes
Countries
- United States
- Australia
- Canada
- New Zealand
- Puerto Rico
- Saudi Arabia
Study Locations
More Related Trials
-
Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy
NCT00661011 ·Status: TERMINATED ·Phase: PHASE2
-
Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
NCT00096226 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
NCT00002519 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00033696 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
NCT00003317 ·Status: COMPLETED ·Phase: PHASE3
-
Cisplatin and Pemetrexed With Radiation Followed by Lobectomy
NCT01373463 ·Status: TERMINATED ·Phase: PHASE1
-
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
NCT00095199 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
NCT00352690 ·Status: TERMINATED ·Phase: PHASE2
-
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT01486602 ·Status: COMPLETED ·Phase: PHASE1
-
An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT01711697 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00043108 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer
NCT03866993 ·Status: COMPLETED ·Phase: PHASE3
-
Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
NCT00020007 ·Status: COMPLETED ·Phase: PHASE1
-
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
NCT05624996 ·Status: RECRUITING ·Phase: PHASE3
-
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT00288054 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
NCT00238615 ·Status: TERMINATED ·Phase: PHASE2
-
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
NCT00003159 ·Status: COMPLETED ·Phase: PHASE3
-
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
NCT00030771 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer
NCT00686959 ·Status: COMPLETED ·Phase: PHASE3
-
Osteosarcoma Maintenance Therapy With OST31-164
NCT04974008 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer
NCT00510445 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
NCT00003860 ·Status: COMPLETED ·Phase: PHASE2
-
Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)
NCT06031246 ·Status: RECRUITING ·Phase: PHASE3
-
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
NCT02273375 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage
NCT03523234 ·Status: UNKNOWN ·Phase: NA